DWTX
Dogwood Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.29
−2.14%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−2.3x
Market Cap
$77.84M
MomentumView details →
1D Return
−2.14%
YTD Return
−44.95%
RSI (14)
53.0
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−2.3x
Market Cap
$77.84M
RSI (14)
53.0
MomentumView details →
1D Return
−2.14%
YTD Return
−44.95%
SummaryUpdated Jun 1, 2026
Dogwood Therapeutics, Inc. (NASDAQ:DWTX) is a development-stage biotechnology company founded in 2012 and headquartered in Alpharetta, Georgia. The company was formerly known as Virios Therapeutics, Inc. before changing its name to Dogwood Therapeutics in October 2024. As a clinical-stage biotech firm, Dogwood focuses on developing novel antiviral therapies designed to treat diseases associated with viral-triggered abnormal immune responses, representing a specialized approach within the broader biotechnology industry.
Similar companies
Latest newsMore news →